These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1206 related items for PubMed ID: 16213299

  • 21. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH.
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [Abstract] [Full Text] [Related]

  • 22. [Hepatita B and C virus infections in patients with hepatocellular carcinoma].
    Crespo J, Dueñas C, Sánchez-Antolín G, Fábrega E, Carte B, Pons-Romero F.
    Med Clin (Barc); 1996 Feb 24; 106(7):241-5. PubMed ID: 8667672
    [Abstract] [Full Text] [Related]

  • 23. Impact of hepatitis B and C virus infection on the outcome of kidney transplantation in Chinese patients.
    Huo TI, Yang WC, Wu JC, King KL, Loong CC, Lin CY, Lui WY, Chang FY, Lee SD.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb 24; 63(2):93-100. PubMed ID: 10677918
    [Abstract] [Full Text] [Related]

  • 24. Does hepatitis C virus affect the reactivation of hepatitis B virus following renal transplantation?
    Yen TH, Huang CC, Lin HH, Huang JY, Tian YC, Yang CW, Wu MS, Fang JT, Yu CC, Chiang YJ, Chu SH.
    Nephrol Dial Transplant; 2006 Apr 24; 21(4):1046-52. PubMed ID: 16390851
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of HBV and HCV antigens expression in correlation with HBV DNA and HCV RNA occurrence in liver biopsy specimens of patients with chronic hepatitis type B and chronic hepatitis type C, respectively.
    Walewska-Zielecka B, Swiderska H, Jończyk M, Nowosławski A.
    Med Sci Monit; 2001 May 24; 7 Suppl 1():147-50. PubMed ID: 12211710
    [Abstract] [Full Text] [Related]

  • 26. High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy.
    Laurent C, Bourgeois A, Mpoudi-Ngolé E, Kouanfack C, Ciaffi L, Nkoué N, Mougnutou R, Calmy A, Koulla-Shiro S, Ducos J, Delaporte E.
    HIV Med; 2010 Jan 24; 11(1):85-9. PubMed ID: 19659944
    [Abstract] [Full Text] [Related]

  • 27. Subclinical reactivation of hepatitis B virus in liver transplant recipients with past exposure.
    Abdelmalek MF, Pasha TM, Zein NN, Persing DH, Wiesner RH, Douglas DD.
    Liver Transpl; 2003 Dec 24; 9(12):1253-7. PubMed ID: 14625824
    [Abstract] [Full Text] [Related]

  • 28. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia.
    Tsatsralt-Od B, Takahashi M, Nishizawa T, Inoue J, Ulaankhuu D, Okamoto H.
    Arch Virol; 2005 Dec 24; 150(12):2513-28. PubMed ID: 16012782
    [Abstract] [Full Text] [Related]

  • 29. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M.
    J Exp Clin Cancer Res; 1999 Sep 24; 18(3):379-89. PubMed ID: 10606185
    [Abstract] [Full Text] [Related]

  • 30. Mutual confounding and interactive effects between hepatitis C and hepatitis B viral infections in hepatocellular carcinogenesis: a population-based case-control study in Taiwan.
    Sun CA, Farzadegan H, You SL, Lu SN, Wu MH, Wolfe L, Hardy W, Huang GT, Yang PM, Lee H, Chen CJ.
    Cancer Epidemiol Biomarkers Prev; 1996 Mar 24; 5(3):173-8. PubMed ID: 8833617
    [Abstract] [Full Text] [Related]

  • 31. Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity.
    Kim KH, Ahn SH, Chung HY, Paik YH, Lee KS, Kim YS, Chon CY, Moon YM, Han KH.
    J Gastroenterol Hepatol; 2004 Aug 24; 19(8):847-53. PubMed ID: 15242485
    [Abstract] [Full Text] [Related]

  • 32. Low HBV-DNA levels in end-stage renal disease patients with HBeAg-negative chronic hepatitis B.
    Moutinho RS, Perez RM, Medina-Pestana JO, Figueiredo MS, Koide S, Alberto FL, Silva AE, Ferraz ML.
    J Med Virol; 2006 Oct 24; 78(10):1284-8. PubMed ID: 16927290
    [Abstract] [Full Text] [Related]

  • 33. Different kinetics of HBV and HCV during haemodialysis and absence of seronegative viral hepatitis in patients with end-stage renal disease.
    Mederacke I, Meier M, Lüth JB, Schmidt-Gürtler H, Raupach R, Horn-Wichmann R, Wursthorn K, Potthoff A, Colucci G, Manns MP, Wedemeyer H, Tillmann HL.
    Nephrol Dial Transplant; 2011 Aug 24; 26(8):2648-56. PubMed ID: 21273235
    [Abstract] [Full Text] [Related]

  • 34. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
    Rodríguez-Torres M, Gonzalez-Garcia J, Bräu N, Solá R, Moreno S, Rockstroh J, Smaill F, Mendes-Correa MC, DePamphilis J, Torriani FJ, APRICOT Investigators.
    J Med Virol; 2007 Jun 24; 79(6):694-700. PubMed ID: 17457912
    [Abstract] [Full Text] [Related]

  • 35. HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course.
    Sagnelli E, Coppola N, Messina V, Di Caprio D, Marrocco C, Marotta A, Onofrio M, Scolastico C, Filippini P.
    Hepatology; 2002 Nov 24; 36(5):1285-91. PubMed ID: 12395342
    [Abstract] [Full Text] [Related]

  • 36. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
    Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G.
    N Engl J Med; 1999 Jul 01; 341(1):22-6. PubMed ID: 10387938
    [Abstract] [Full Text] [Related]

  • 37. Two HBV DNA+/HBsAg- blood donors identified by HBV NAT in Shenzhen, China.
    Shang G, Yan Y, Yang B, Shao C, Wang F, Li Q, Seed CR.
    Transfus Apher Sci; 2009 Aug 01; 41(1):3-7. PubMed ID: 19487161
    [Abstract] [Full Text] [Related]

  • 38. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH, Kao JH, Chen PJ, Huang LM, Chang SY, Sun HY, Hung CC, Chen MY, Chang SC.
    Clin Infect Dis; 2007 Nov 01; 45(9):1221-9. PubMed ID: 17918088
    [Abstract] [Full Text] [Related]

  • 39. HBV DNA integration and HBV-transcript expression in non-B, non-C hepatocellular carcinoma in Japan.
    Tamori A, Nishiguchi S, Kubo S, Narimatsu T, Habu D, Takeda T, Hirohashi K, Shiomi S.
    J Med Virol; 2003 Dec 01; 71(4):492-8. PubMed ID: 14556260
    [Abstract] [Full Text] [Related]

  • 40. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S, Shibuya A, Miura Y, Takeuchi A, Nakazawa T, Saigenji K.
    Scand J Gastroenterol; 2008 Dec 01; 43(7):849-56. PubMed ID: 18584524
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 61.